Brief: Fusen Pharmaceutical Says Subscription Of Interest In Limited Liability Partnership
16/04/2024 13:34
April 16 (Reuters) - Fusen Pharmaceutical Co Ltd
1652.HK :
* SUBSCRIPTION OF INTEREST IN LIMITED LIABILITY PARTNERSHIP-
AND
ENTERING INTO LIMITED PARTNERSHIP AGREEMENT
* AGREEMENT IN RELATION TO FORMATION OF LIMITED LIABILITY
PARTNERSHIP
* PARTNERSHIP TO ENGAGE IN INVESTMENTS BUSINESS
* UNIT ENTERED LIMITED PARTNERSHIP AGREEMENT WITH CHINA
UNITED
INNOVATIVE (BEIJING) TECHNOLOGY DEVELOPMENT, AMONG OTHERS
* UNIT'S TOTAL CAPITAL COMMITMENT IN PARTNERSHIP IS RMB85
MILLION
* TOTAL CAPITAL COMMITMENT TO PARTNERSHIP IS RMB125 MILLION
Further company coverage: 1652.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusen Pharmaceutical
See all newsBrief: Fusen Pharmaceutical Logs HY Loss Attributable RMB13.6 Million
Brief: Fusen Pharmaceutical Says Doxazosin Mesylate Extended-Release Tablets Approved For Marketing In China
Brief: Fusen Pharmaceutical Says Peramivir Injection First Neuraminidase Inhibitor Approved In China For Intravenous Influenza Treatment
Brief: Fusen Pharmaceutical Says Investors To Contribute RMB300 Mln For 34% Stake Subscription Of Henan Fusen Pharmaceutical
Brief: Fusen Pharmaceutical Says Piracetam Injection Approved For Marketing By NMPA